MYLAN 6727 MYLAN 6727 (Zonisamide 100 mg)
Pill with imprint MYLAN 6727 MYLAN 6727 is Purple / Blue, Capsule-shape and has been identified as Zonisamide 100 mg. It is supplied by Mylan Pharmaceuticals Inc..
Zonisamide is used in the treatment of migraine prevention; seizures; parkinsonian tremor; benign essential tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 6727 MYLAN 6727
Zonisamide
- Imprint:
- MYLAN 6727 MYLAN 6727
- Strength:
- 100 mg
- Color:
- Purple / Blue
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- lactose anhydrous
ferrosoferric oxide
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
microcrystalline cellulose
propylene glycol
shellac
sodium lauryl sulfate
titanium dioxide
FD&C Red No. 3
gelatin
magnesium stearate
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0768 | UDL Laboratories Inc. |
More about zonisamide
- Zonisamide Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 87 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
Consumer resources
Other brands: Zonegran
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
